T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

被引：0
|
作者：
K Mihara
J Bhattacharyya
A Kitanaka
K Yanagihara
T Kubo
Y Takei
H Asaoku
Y Takihara
A Kimura
机构：
[1] Research Institute for Radiation Biology and Medicine,Department of Hematology and Oncology
[2] Hiroshima University,Department of Laboratory Medicine
[3] Faculty of Medicine,Department of Life Science
[4] Kagawa University,Department of Biochemistry
[5] Yasuda Women’s University Faculty of Pharmacy,Department of Clinical Laboratory
[6] Nagoya University Graduate School of Medicine,Department of Stem Cell Biology
[7] Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital,undefined
[8] Research Institute for Radiation Biology and Medicine,undefined
[9] Hiroshima University,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 367
页数：2
相关论文
共 50 条
  • [41] Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
    Lee, Yong Gu
    Guruprasad, Puneeth
    Ghilardi, Guido
    Pajarillo, Raymone
    Sauter, Christopher Tor
    Patel, Ruchi
    Ballard, Hatcher J.
    Hong, Seok Jae
    Chun, Inkook
    Yang, Nicholas
    V. Amelsberg, Kimberly
    Cummins, Katherine D.
    Svoboda, Jakub
    Gill, Saar
    Chong, Elise A.
    North, Khrystyna
    Church, Sarah E.
    Fraietta, Joseph A.
    Chang, Wan -Jung
    Lacey, Simon F.
    Lu, Xueqing Maggie
    Zhang, Yunlin
    Whig, Kanupriya
    Schultz, David C.
    Cherry, Sara
    Gerson, Jame
    Schuster, Stephen J.
    Porazzi, Patrizia
    Ruella, Marco
    CANCER DISCOVERY, 2022, 12 (10) : 2372 - 2391
  • [42] The Role of CD38 in Multiple Myeloma Cell Biology
    Kawano, Yawara
    Kushima, Saki
    Hata, Hiroyuki
    Matsuoka, Masao
    BLOOD, 2021, 138
  • [43] Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells
    David Marc Davies
    John Maher
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 165 - 178
  • [44] Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells
    Davies, David Marc
    Maher, John
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (03) : 165 - 178
  • [45] Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma
    Fayon, Maxime
    Martinez-Cingolani, Carolina
    Abecassis, Audrey
    Roders, Nathalie
    Nelson, Elisabeth
    Choisy, Caroline
    Talbot, Alexis
    Bensussan, Armand
    Fermand, Jean-Paul
    Arnulf, Bertrand
    Bories, Jean-Christophe
    HAEMATOLOGICA, 2021, 106 (04) : 1193 - 1197
  • [46] Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas
    Scarfo, Irene
    Ormhoj, Maria
    Frigault, Matthew J.
    Castano, Ana P.
    Lorrey, Selena
    Bouffard, Amanda A.
    van Scoyk, Alexandria
    Rodig, Scott J.
    Shay, Alexandra J.
    Aster, Jon C.
    Preffer, Frederic, I
    Weinstock, David M.
    Maus, Marcela, V
    BLOOD, 2018, 132 (14) : 1495 - 1506
  • [47] Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma
    Roders, Nathalie
    Nakid-Cordero, Cecilia
    Raineri, Fabio
    Fayon, Maxime
    Abecassis, Audrey
    Choisy, Caroline
    Nelson, Elisabeth
    Maillard, Claire
    Garrick, David
    Talbot, Alexis
    Fermand, Jean-Paul
    Arnulf, Bertrand
    Bories, Jean-Christophe
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (04) : 478 - 490
  • [48] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
  • [49] Co-Targeting CD38 with a Chimeric Costimulatory Receptor Enhances Adoptive T Cell Therapy for Hematological Malignancies
    Katsarou, Afroditi
    Sjostrand, Maria L.
    Nianias, Alexandros
    Poels, Renee
    Zweegman, Sonja
    Mutis, Tuna
    Sadelain, Michel
    Groen, Richard W. J.
    Themeli, Maria
    MOLECULAR THERAPY, 2020, 28 (04) : 40 - 41
  • [50] Chimeric Antigen Receptor T Cells: Immunotherapy for the Treatment of Leukemia, Lymphoma, and Myeloma
    Rodriguez Gil de Montes, Angibelle Lizmar
    Spencer, Lilian Maritza
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (11) : 1261 - 1269
12345